ABURATANI HIROYUKI has a total of 24 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PANIMA PHARMACEUTICALS AG, BIOGEN INTERNAT NEUROSCIENCE GMBH and BIOGEN IDEC INTERNAT NEUROSCIENCE GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Medical preparations | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Aburatani Hiroyuki | 24 |
#2 | Ito Hirotaka | 12 |
#3 | Ito Yukio | 10 |
#4 | Ohtomo Toshihiko | 10 |
#5 | Hippo Yoshitaka | 10 |
#6 | Arai Masahiro | 6 |
#7 | Watanabe Akira | 6 |
#8 | Fukayama Masashi | 6 |
#9 | Kinoshita Yasuko | 6 |
#10 | Funahashi Shin-Ichi | 5 |
Publication | Filing date | Title |
---|---|---|
US2012128678A1 | Diagnosis and treatment of cancer using anti-TMPRSS11E antibody | |
US2010316568A1 | Diagnostic agent and therapeutic agent for pancreatic cancer | |
US2007212359A1 | Cancer diagnosis and treatment of cancer using anti-robo 1 antibody | |
EP2226636A1 | Cancer diagnosis and treatment using anti-robo1 antibody | |
WO2005023301A1 | Remedy and detection drug for bile duct cancer | |
WO2004061103A1 | Novel protein and its gene |